A Review of the Pharmacological Management of Anxiety Disorders

This review highlights current as well as emerging pharmacotherapy for the management of anxiety disorders.

Educational Objectives

Educational Aim:
The aim of this article is to enable healthcare professionals to know the different therapeutic alternatives available to manage anxiety disorders.

Editor's comments:
It is important to consider each patient individually and consider which agent best suits them by considering their potential side effects, drug interactions and the patient as a whole..

Educational Outcomes:
Upon completion of this module practitioners should have a clear understanding of:

1. The use of Serotonergic/Norepinephrinergic Antidepressants in Anxiety Disorders

2. The use of Mixed Antidepressants in Anxiety Disorders
3. The use of monoamine oxidase inhibitors (MAOIs) in Anxiety Disorders
4. The use of Benzodiazepines in Anxiety Disorders
5. The use of Anti-Epileptic Agents in Anxiety Disorders
6. The use of Antihistamines in Anxiety Disorders
7. The use of Alpha- and Beta-Adrenergic Agents in Anxiety Disorders
8. The use of Antipsychotic Agents in Anxiety Disorders
9. The use of Neuropeptides in Anxiety Disorders
10. The use of Neurosteroids in Anxiety Disorders
11. The use of Cannabinoids in Anxiety Disorders.

Instructions for this Module

• Read the supplied reading material and complete the quiz that follows;
• You have three attempts to pass the quiz;
• The pass grade is 70%;
• You need to pass the quiz to claim your CPD certificate;
• Please click on the CPD certificate link below to claim your CPD certificate and to update your CPD Manager.

If you need any assistance to complete this module, please Contact us